Respiratory
Our deep understand of clinical development in Pulmonary and seasonal respiratory therapies has helped us consult on study designs, protocol writing, advanced database set-up, to complex Statistical analysis. Our best in class support has helped get support and confidence of start-up biotechs to help them prepare for seed funding meetings. We understand the cost constraints of generic pharmaceuticals and provide end-to-end support of respiratory endpoint studies.
TCell has completed respiratory studies with a wide range of therapeutic interventions, including corticosteroids, bronchodilators, antibiotics, and kinase inhibitors.